As insurance professionals, you provide valuable support to individuals and families. Understanding how to support clients who are either already diagnosed or show possible onset symptoms of Alzheimer’s disease gives […]
The Centers for Medicare & Medicaid Services (CMS) revealed on Thursday, August 31st 2023, that the initial group of ten Medicare Part D medications slated for negotiation under the Inflation Reduction Act (IRA) has been identified.
These drugs have been designated based on the outlined criteria within the IRA. This legislation mandates that CMS prioritize drugs with the highest Medicare expenditure and minimal competition, among other […]
Happy August Brokers! AEP is fast approaching, and we are here to help you prepare! Considering this month’s focus on Immunization Awareness, we want to ensure you’re well-prepared with the […]
Around this time every year Center for Medicare and Medicaid Services (CMS) releases the benefit parameters for Part D’s “Defined Standard Benefit” plan, as well as the parameters for the […]
The Centers for Medicare & Medicaid Services (CMS) announced an increase to the maximum broker commissions for Medicare Advantage & Medicare Part D plans in 2022.
CMS has released the maximum broker commissions for Medicare Advantage and Medicare Part D for 2021. Please note: compensation varies by carrier. The carriers are not required to pay the CMS maximum amount.
For the 5th year in a row, CMS has raised the maximum rates of Broker and Agent commissions for Medicare Advantage Plans and Prescription Drug Plans. Here are some of the highlights.
The Centers for Medicare & Medicaid Services (CMS) recently released premium and cost-sharing information for Part D plans for the 2020 calendar year. Below are the highlights of a preliminary analysis.
Today, the Centers for Medicare & Medicaid Services (CMS) announced that, for the second year in a row, the average basic premium for a Medicare Part D prescription drug plan in 2019 is projected to decline.